 | Up a level |
Harrington, Kevin J. and Burtness, Barbara and Greil, Richard and Soulieres, Denis and Tahara, Makoto and de Castro Jr, Gilberto and Psyrri, Amanda and Brana, Irene and Baste, Neus and Neupane, Prakash and Bratland, Ase and Fuereder, Thorsten and Hughes, Brett G. M. and Mesia, Ricard and Ngamphaiboon, Nuttapong and Rordorf, Tamara and Wan Ishak, Wan Zamaniah and Lin, Jianxin and Gumuscu, Burak and Swaby, Ramona F. and Rischin, Danny (2023) Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Opdated results of the phase III keynote-048 study. Journal of Clinical Oncology, 41 (4). 790+. ISSN 0732183X, DOI https://doi.org/10.1200/JCO.21.02508.
Keam, B. and Machiels, J-P and Kim, H. R. and Licitra, L. and Golusinski, W. and Gregoire, V and Lee, Y. G. and Belka, C. and Guo, Y. and Rajappa, S. J. and Tahara, M. and Azrif, M. and Ang, M. K. and Yang, M-H and Wang, C-H and Ng, Q. S. and Wan Ishak, Wan Zamaniah and Kiyota, N. and Babu, S. and Yang, K. and Curigliano, G. and Peters, S. and Kim, T. W. and Yoshino, T. and Pentheroudakis, G. (2021) Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck. ESMO Open, 6 (6). ISSN 2059-7029, DOI https://doi.org/10.1016/j.esmoop.2021.100309.
